Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

Phase 4

Completed

• Conditions: Hypertension
• Interventions: Drug: trandolapril/verapamil

• Registration Number: NCT00235001
• Lead Sponsor: Abbott

Brief Summary

This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)

Detailed Description

Not available

Study Timeline

• Study Start: 2004-06
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-10-07
• Study First Posted: 2005-10-10
• Primary Completion: 2006-11
• Status Verified: 2008-07
• Last Update Submitted: 2008-07-09
• Last Update Posted: 2008-07-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Hypertension

Exclusion Criteria

• SBP > 180 mm Hg, DBP > 114 mm Hg
• Subject has a hypersensitivity to trandolapril or verapamil

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	trandolapril/verapamil	-

Primary Outcome Measures

Name	Time	Method
Change in blood pressure from baseline/blood pressure control	Baseline to 3 months of Tx

Secondary Outcome Measures

Name	Time	Method
Absolute BP reduction from baseline, safety	Baseline to 3 months of Tx

Trial Locations

Locations (1)

Global Medical Information-Abbott; 🇺🇸 North Chicago, Illinois, United States